Read NVHR’s 2023 Year In Review & check out our 2024-2026 Strategic Plan

Press Release: NVHR celebrates FDA approval of first-ever hepatitis C RNA point-of-care test 

Press Release: New CDC Report Reveals Only 1/3 of Hep C Diagnoses Lead to Cures, Spotlighting a Broken System in Dire Need of Coordinated National Response 

Press Release: CHLPI & NVHR Statement on New CDC Report Revealing Gaps in Hepatitis C Treatment in the Cherokee Nation 

Press Release: South Dakota Medicaid removes fibrosis and sobriety requirements for hepatitis C treatment

Press Release: Alongside a majority of U.S. voters, American Pharmacists Association now supports decriminalizing personal possession and use of illicit drugs

Press Release: National Viral Hepatitis Roundtable Applauds White House Proposal for a National Hepatitis C Elimination Plan

Press Release: 2023 Hep C: State of Medicaid Access Report Cards Are In

Press Release: Colorado, Oregon, and Texas Are Lifting Barriers to HCV Treatment for Medicaid Recipients 

Press Release: Alabama Medicaid removes sobriety requirements for hepatitis C treatment

Press Release: Arizona Medicaid removes prior authorization requirements for hepatitis C treatment

Press Release: Washington, D.C. Medicaid Removes Restrictions to Hepatitis C Treatment, Increasing Access for Medicaid Recipients

Press Release: CHLPI & NVHR Statement on New CDC Data Revealing Impact of Insurance Barriers on Hepatitis C Treatment Access

Press Release: NVHR Statement on House Appropriations Committee FY23 Viral Hepatitis Funding Levels for Departments of Labor, Health and Human Services, and Education

Press Release: NVHR Statement on Favorable Report of the “Restoring Hope for Mental Health and Well-Being Act of 2022” (H.R. 7666) by the House Committee on Energy & Commerce

Press Release: NVHR Applauds Complaint Against Alabama Medicaid for Denial of HCV Treatment for People with Substance Use Disorder

Press Release: NVHR Statement on the Biden-Harris Administration’s National Drug Control 2022 Strategy Release

Press Release: Joint Statement from Leading HIV/AIDS and Viral Hepatitis Advocates regarding Manufacturer Action on the 340B Drug Pricing Program

Press Release: NVHR Statement on CDC’s Formal Adoption of Hepatitis B Vaccination Recommendation for All Adults 19-59

Press Release: NVHR Statement on President Biden’s FY2023 Budget Proposal for Viral Hepatitis and Related Program Funding

Press Release: NVHR Statement on Omnibus Spending Bill Funding Levels for Viral Hepatitis and Related Programs